Glycogen storage disease (GSD) type III (OMIM 232400) is due to glycogen debranching enzyme (GDE; EC 3.2.1.33) deficiency encoded by the AGL gene. The estimated incidence of the disease is estimated ...

NOVATO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the U.S. Food and Drug Administration (FDA or the Agency) has accepted for review the ...

Glycogen storage disease type III (GSD III; McKusick, 232,400) is an autosomal recessive disease caused by the deficiency of glycogen-debranching enzyme (amylo-1,6-glucosidase, AGL). AGL contains two ...

Ahmedabad: The city recently got the national biobank for lysosomal storage disorders at the FRIGE Institute of Human Genetics. Lysosomal storage disorders (LSDs) are a diverse group of over 70 rare, ...

A team of researchers has linked neuronal activity to the levels of sphingolipids, a type of fat, in brain cells. Furthermore, disruption of sphingolipid metabolism led to significant neuronal damage ...

The first-year seminars introduce students to bioengineering as a discipline and also introduce them to the research activities in the department of bioengineering. (1 unit) Material and energy ...